Guggenheim Capital’s Nuveen Real Asset Income & Growth Fund JRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.96M Buy
241,003
+22,440
+10% +$292K 0.02% 581
2025
Q4
$2.97M Buy
218,563
+29,953
+16% +$412K 0.02% 566
2025
Q3
$2.69M Buy
188,610
+32,345
+21% +$437K 0.02% 605
2025
Q2
$2.11M Buy
156,265
+42,626
+38% +$544K 0.02% 645
2025
Q1
$1.47M Buy
113,639
+40,054
+54% +$509K 0.01% 738
2024
Q4
$893K Buy
73,585
+37,080
+102% +$485K 0.01% 970
2024
Q3
$499K Sell
36,505
-305
-0.8% -$3.9K ﹤0.01% 1407
2024
Q2
$448K Buy
36,810
+258
+0.7% +$2.99K ﹤0.01% 1481
2024
Q1
$434K Buy
36,552
+12,605
+53% +$146K ﹤0.01% 1526
2023
Q4
$281K Buy
+23,947
New +$258K ﹤0.01% 1694
2022
Q3
Sell
-45,576
Closed -$596K 1978
2022
Q2
$596K Buy
45,576
+6,920
+18% +$97.5K ﹤0.01% 1492
2022
Q1
$591K Buy
38,656
+15,929
+70% +$240K ﹤0.01% 1618
2021
Q4
$366K Sell
22,727
-267
-1% -$4.15K ﹤0.01% 1800
2021
Q3
$351K Sell
22,994
-2,702
-11% -$43.2K ﹤0.01% 1870
2021
Q2
$412K Sell
25,696
-20,000
-44% -$313K ﹤0.01% 1909
2021
Q1
$673K Sell
45,696
-1,153
-2% -$16.2K ﹤0.01% 1573
2020
Q4
$631K Buy
46,849
+15,583
+50% +$198K ﹤0.01% 1539
2020
Q3
$377K Buy
31,266
+14,208
+83% +$172K ﹤0.01% 1551
2020
Q2
$200K Buy
17,058
+395
+2% +$4.39K ﹤0.01% 1750
2020
Q1
$164K Sell
16,663
-656
-4% -$10.7K ﹤0.01% 1707
2019
Q4
$318K Buy
17,319
+4,744
+38% +$84.8K ﹤0.01% 1795
2019
Q3
$220K Sell
12,575
-7,461
-37% -$127K ﹤0.01% 1976
2019
Q2
$340K Sell
20,036
-8,637
-30% -$140K ﹤0.01% 1820
2019
Q1
$460K Sell
28,673
-1,338
-4% -$20.6K ﹤0.01% 1715
2018
Q4
$409K Sell
30,011
-329
-1% -$4.87K ﹤0.01% 1770
2018
Q3
$489K Sell
30,340
-1,561
-5% -$25.4K ﹤0.01% 1996
2018
Q2
$516K Sell
31,901
-1,278
-4% -$20.8K ﹤0.01% 1936
2018
Q1
$538K Buy
33,179
+2,442
+8% +$41.4K ﹤0.01% 2355
2017
Q4
$547K Buy
30,737
+9,947
+48% +$176K ﹤0.01% 2329
2017
Q3
$374K Buy
+20,790
New +$375K ﹤0.01% 2483
2017
Q1
Sell
-22,887
Closed -$360K 2890
2016
Q4
$360K Sell
22,887
-10,811
-32% -$174K ﹤0.01% 2528
2016
Q3
$581K Sell
33,698
-18,673
-36% -$323K ﹤0.01% 2329
2016
Q2
$885K Sell
52,371
-42,789
-45% -$677K ﹤0.01% 2125
2016
Q1
$1.46M Sell
95,160
-29,258
-24% -$418K ﹤0.01% 1795
2015
Q4
$1.9M Sell
124,418
-17,888
-13% -$284K 0.01% 1649
2015
Q3
$2.09M Sell
142,306
-31,994
-18% -$534K 0.01% 1560
2015
Q2
$3.01M Sell
174,300
-17,182
-9% -$327K 0.01% 1454
2015
Q1
$3.74M Sell
191,482
-15,388
-7% -$298K 0.01% 1328
2014
Q4
$3.9M Sell
206,870
-19,809
-9% -$392K 0.01% 1258
2014
Q3
$4.4M Buy
226,679
+16,805
+8% +$333K 0.01% 1260
2014
Q2
$4.26M Buy
209,874
+69,596
+50% +$1.35M 0.01% 1275
2014
Q1
$2.58M Buy
140,278
+33,587
+31% +$597K 0.01% 1571
2013
Q4
$1.79M Buy
106,691
+378
+0.4% +$6.83K 0.01% 1876
2013
Q3
$1.99M Buy
106,313
+2,697
+3% +$49.6K 0.01% 1633
2013
Q2
$1.94M Buy
+103,616
New +$2.06M 0.01% 1561

Other funds holding JRI

Guggenheim Capital's JRI Position: Q1 2026 in Review

Guggenheim Capital increased its Nuveen Real Asset Income & Growth Fund (JRI) stake by 10% in Q1 2026, buying an estimated $292K and bringing the position to 241,003 shares worth $2.96M. The position accounts for 0.02% of the portfolio, ranked #581.

Guggenheim Capital first reported a position in JRI in Q2 2013 and has held it in 45 quarters since. The position peaked at $4.4M in Q3 2014. 91 funds tracked by Wall St. Rank hold JRI as of Q1 2026.

  • Guggenheim Capital held 241,003 shares of Nuveen Real Asset Income & Growth Fund worth $2.96M as of Q1 2026.
  • Guggenheim Capital bought 22,440 Nuveen Real Asset Income & Growth Fund shares in Q1 2026, an estimated $292K.
  • Nuveen Real Asset Income & Growth Fund made up 0.02% of Guggenheim Capital's portfolio in Q1 2026, its #581 holding.
  • Guggenheim Capital first reported a position in Nuveen Real Asset Income & Growth Fund in Q2 2013 and has held it in 45 quarters since.
  • Guggenheim Capital's Nuveen Real Asset Income & Growth Fund position peaked at $4.4M in Q3 2014.
  • 91 funds tracked by Wall St. Rank held Nuveen Real Asset Income & Growth Fund as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.